Evidence map›Paper›PMID 33028914›Full record

Observational studyScientific reports2020

A novel severity score to predict inpatient mortality in COVID-19 patients.

David J Altschul, Santiago R Unda, Joshua Benton, Rafael de la Garza Ramos, Phillip Cezayirli, Mark Mehler, Emad N Eskandar

Abstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Performance of Risk Scores in SARS-CoV-2 Infection: A Retrospective Study.International journal of environmental research and public health · 2025
    Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Hemodynamic, Oxygenation and Lymphocyte Parameters Predict COVID-19 Mortality.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David J AltschulDepartment of Neurological Surgery, Montefiore Medical Center, 3316 Rochambeau Ave., Bronx, NY, 10467, USA. daltschu@montefiore.org.
Santiago R UndaDepartment of Neurological Surgery, Montefiore Medical Center, 3316 Rochambeau Ave., Bronx, NY, 10467, USA. Santiagounda94@gmail.com.
Joshua BentonDepartment of Neurological Surgery, Montefiore Medical Center, 3316 Rochambeau Ave., Bronx, NY, 10467, USA.
Rafael de la Garza RamosDepartment of Neurological Surgery, Montefiore Medical Center, 3316 Rochambeau Ave., Bronx, NY, 10467, USA.
Phillip CezayirliDepartment of Neurological Surgery, Montefiore Medical Center, 3316 Rochambeau Ave., Bronx, NY, 10467, USA.
Mark MehlerDepartment of Neurology, Montefiore Medical Center, Bronx, NY, USA.
Emad N EskandarDepartment of Neurological Surgery, Montefiore Medical Center, 3316 Rochambeau Ave., Bronx, NY, 10467, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is commonly mild and self-limiting, but in a considerable portion of patients the disease is severe and fatal. Determining which patients are at high risk of severe illness or mortality is essential for appropriate clinical decision making. We propose a novel severity score specifically for COVID-19 to help predict disease severity and mortality. 4711 patients with confirmed SARS-CoV-2 infection were included. We derived a risk model using the first half of the cohort (n = 2355 patients) by logistic regression and bootstrapping methods. The discriminative power of the risk model was assessed by calculating the area under the receiver operating characteristic curves (AUC). The severity score was validated in a second half of 2356 patients. Mortality incidence was 26.4% in the derivation cohort and 22.4% in the validation cohort. A COVID-19 severity score ranging from 0 to 10, consisting of age, oxygen saturation, mean arterial pressure, blood urea nitrogen, C-Reactive protein, and the international normalized ratio was developed. A ROC curve analysis was performed in the derivation cohort achieved an AUC of 0.824 (95% CI 0.814-0.851) and an AUC of 0.798 (95% CI 0.789-0.818) in the validation cohort. Furthermore, based on the risk categorization the probability of mortality was 11.8%, 39% and 78% for patient with low (0-3), moderate (4-6) and high (7-10) COVID-19 severity score. This developed and validated novel COVID-19 severity score will aid physicians in predicting mortality during surge periods.

Indexed as

BetacoronavirusHospital MortalityResearch DesignSeverity of Illness IndexAdultAgedAged, 80 and overAge FactorsArterial PressureBlood Urea NitrogenCoronavirus InfectionsCOVID-19C-Reactive ProteinFemaleHumansMaleC-Reactive Protein

Identifiers

PMID33028914
PMCPMC7542454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.